Detailed information for compound 186947

Basic information

Technical information
  • TDR Targets ID: 186947
  • Name: 5-(4-amino-5,8-difluorospiro[1H-quinazoline-2 ,4'-piperidine]-1'-carbonyl)pyridine-2-carbon itrile
  • MW: 382.367 | Formula: C19H16F2N6O
  • H donors: 2 H acceptors: 3 LogP: 1.25 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: N#Cc1ccc(cn1)C(=O)N1CCC2(CC1)N=C(N)c1c(N2)c(F)ccc1F
  • InChi: 1S/C19H16F2N6O/c20-13-3-4-14(21)16-15(13)17(23)26-19(25-16)5-7-27(8-6-19)18(28)11-1-2-12(9-22)24-10-11/h1-4,10,25H,5-8H2,(H2,23,26)
  • InChiKey: GIZYIOOBBUHOBS-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-(4-amino-5,8-difluoro-spiro[1H-quinazoline-2,4'-piperidine]-1'-carbonyl)pyridine-2-carbonitrile
  • 5-[(4-amino-5,8-difluoro-1'-spiro[1H-quinazoline-2,4'-piperidine]yl)-oxomethyl]-2-pyridinecarbonitrile
  • 5-(4-azanyl-5,8-difluoro-spiro[1H-quinazoline-2,4'-piperidine]-1'-yl)carbonylpyridine-2-carbonitrile
  • 5-(4-amino-5,8-difluoro-spiro[1H-quinazoline-2,4'-piperidine]-1'-carbonyl)picolinonitrile
  • 5-(4-amino-5,8-difluoro-spiro[1H-quinazoline-2,4'-piperidine]-1'-yl)carbonylpyridine-2-carbonitrile

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens nitric oxide synthase 2, inducible Starlite/ChEMBL References
Homo sapiens nitric oxide synthase 1 (neuronal) Starlite/ChEMBL References
Homo sapiens potassium voltage-gated channel, subfamily H (eag-related), member 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni voltage-gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Loa Loa (eye worm) voltage and ligand gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Echinococcus granulosus potassium voltage gated channel subfamily H Get druggable targets OG5_128858 All targets in OG5_128858
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma japonicum ko:K04910 potassium voltage-gated channel, Eag-related subfamily H, member 7, putative Get druggable targets OG5_128858 All targets in OG5_128858
Trichomonas vaginalis voltage and ligand gated potassium channel, putative Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma japonicum Potassium voltage-gated channel subfamily H member 2, putative Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma japonicum ko:K04910 potassium voltage-gated channel, Eag-related subfamily H, member 7, putative Get druggable targets OG5_128858 All targets in OG5_128858
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma mansoni voltage-gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Trichomonas vaginalis voltage and ligand gated potassium channel, putative Get druggable targets OG5_128858 All targets in OG5_128858
Echinococcus multilocularis potassium voltage gated channel subfamily H Get druggable targets OG5_128858 All targets in OG5_128858

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0333 1 1
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0013 0.0126 0.0126
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0059 0.1554 0.1178
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0045 0.1103 0.1103
Echinococcus multilocularis methionine synthase reductase 0.0037 0.0856 0.0856
Echinococcus multilocularis isocitrate dehydrogenase (NAD+) 0.004 0.0976 0.0976
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0059 0.1554 0.1178
Brugia malayi flavodoxin family protein 0.0023 0.0426 0.0426
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0045 0.1103 0.1103
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0059 0.1554 1
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.0333 1 1
Leishmania major isocitrate dehydrogenase, putative 0.004 0.0976 0.0574
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0045 0.1103 0.1103
Giardia lamblia Hypothetical protein 0.0052 0.1346 0.5
Toxoplasma gondii isocitrate dehydrogenase 0.0333 1 1
Plasmodium falciparum nitric oxide synthase, putative 0.0059 0.1554 0.1178
Schistosoma mansoni voltage-gated potassium channel 0.0049 0.1229 0.1229
Schistosoma mansoni diflavin oxidoreductase 0.0029 0.0634 0.0634
Schistosoma mansoni unc-13 (munc13) 0.004 0.0976 0.0976
Echinococcus granulosus methionine synthase reductase 0.0037 0.0856 0.0856
Schistosoma mansoni cytochrome P450 reductase 0.0059 0.1554 0.1554
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0023 0.0426 0.2744
Schistosoma mansoni voltage-gated potassium channel 0.0049 0.1229 0.1229
Brugia malayi Isocitrate dehydrogenase 0.0333 1 1
Trypanosoma brucei isocitrate dehydrogenase, putative 0.0333 1 1
Giardia lamblia Nitric oxide synthase, inducible 0.0052 0.1346 0.5
Echinococcus granulosus isocitrate dehydrogenase NAD subunit 0.004 0.0976 0.0976
Schistosoma mansoni Isocitrate dehydrogenase [NAD] subunit gamma mitochondrial 0.004 0.0976 0.0976
Brugia malayi Isocitrate dehydrogenase subunit gamma, mitochondrial precursor 0.004 0.0976 0.0976
Loa Loa (eye worm) isocitrate dehydrogenase 0.0333 1 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0059 0.1554 0.1178
Schistosoma mansoni voltage-gated potassium channel 0.0013 0.0126 0.0126
Leishmania major p450 reductase, putative 0.0059 0.1554 0.1178
Schistosoma mansoni isocitrate dehydrogenase 0.004 0.0976 0.0976
Loa Loa (eye worm) hypothetical protein 0.004 0.0976 0.0976
Plasmodium vivax flavodoxin domain containing protein 0.0052 0.1346 0.0961
Echinococcus granulosus isocitrate dehydrogenase NAD 0.004 0.0976 0.0976
Brugia malayi isocitrate dehydrogenase [NAD] subunit beta, mitochondrial 0.004 0.0976 0.0976
Trypanosoma cruzi p450 reductase, putative 0.0059 0.1554 0.1178
Brugia malayi FAD binding domain containing protein 0.0037 0.0856 0.0856
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0059 0.1554 0.1554
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0037 0.0856 0.0856
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0059 0.1554 0.1178
Wolbachia endosymbiont of Brugia malayi isocitrate dehydrogenase 0.004 0.0976 0.5
Loa Loa (eye worm) hypothetical protein 0.0039 0.0921 0.0921
Mycobacterium leprae PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) 0.004 0.0976 0.5
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0333 1 1
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.0333 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.0037 0.0856 0.0856
Echinococcus multilocularis isocitrate dehydrogenase (NAD) subunit 0.004 0.0976 0.0976
Echinococcus multilocularis isocitrate dehydrogenase 0.0333 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.0059 0.1554 0.1554
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0059 0.1554 0.1554
Schistosoma mansoni voltage-gated potassium channel 0.0013 0.0126 0.0126
Brugia malayi isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial 0.004 0.0976 0.0976
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0059 0.1554 0.1178
Echinococcus multilocularis voltage gated potassium channel 0.0013 0.0126 0.0126
Entamoeba histolytica tartrate dehydrogenase, putative 0.004 0.0976 1
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.0333 1 1
Brugia malayi Probable isocitrate dehydrogenase 0.004 0.0976 0.0976
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0059 0.1554 0.1178
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0023 0.0426 0.2744
Loa Loa (eye worm) flavodoxin family protein 0.0023 0.0426 0.0426
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0059 0.1554 0.1554
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.0333 1 1
Loa Loa (eye worm) hypothetical protein 0.0059 0.1554 0.1554
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0045 0.1103 0.1103
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0059 0.1554 0.1554
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0333 1 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0059 0.1554 0.1178
Trichomonas vaginalis sulfite reductase, putative 0.0059 0.1554 1
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0059 0.1554 0.1178
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0333 1 1
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0333 1 1
Trichomonas vaginalis isocitrate dehydrogenase, putative 0.004 0.0976 0.6279
Chlamydia trachomatis sulfite reductase 0.0037 0.0856 0.5
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0042 0.1012 0.6513
Schistosoma mansoni NADPH flavin oxidoreductase 0.003 0.0648 0.0648
Leishmania major cytochrome P450 reductase, putative 0.0052 0.1346 0.0961
Brugia malayi flavodoxin family protein 0.0059 0.1554 0.1554
Loa Loa (eye worm) isocitrate dehydrogenase gamma subunit 0.004 0.0976 0.0976
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0013 0.0126 0.0126
Brugia malayi FAD binding domain containing protein 0.0059 0.1554 0.1554
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0052 0.1346 0.8664
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0059 0.1554 0.1178
Treponema pallidum flavodoxin 0.0023 0.0426 0.5
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.0013 0.0126 0.0126
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0333 1 1
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0333 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0023 0.0426 0.2744
Brugia malayi Probable isocitrate dehydrogenase 0.004 0.0976 0.0976
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0042 0.1012 0.6513
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0333 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0023 0.0426 0.2744
Loa Loa (eye worm) hypothetical protein 0.0013 0.0126 0.0126
Toxoplasma gondii isocitrate dehydrogenase 0.0333 1 1
Echinococcus granulosus voltage gated potassium channel 0.0013 0.0126 0.0126
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.0333 1 1

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) ~ 10 uM kg-1 Effective dose of compound against acute andchronic models of inflammatory arthritis ChEMBL. 12620067
IC50 (binding) Inhibition of serotonin transporter ChEMBL. 21398123
IC50 (ADMET) Inhibition of CYP2D6 ChEMBL. 21398123
IC50 (binding) Inhibition of NET ChEMBL. 21398123
IC50 (binding) > 4 Inhibition of human eNOS assessed as inhibition of [3H]L-arginine to [3H]L-citrulline conversion by scintillation counting ChEMBL. 21684157
IC50 (binding) = 6.13 Inhibition of human nNOS assessed as inhibition of [3H]L-arginine to [3H]L-citrulline conversion by scintillation counting ChEMBL. 21684157
IC50 (binding) = 7.43 Inhibition of human iNOS assessed as inhibition of [3H]L-arginine to [3H]L-citrulline conversion by scintillation counting ChEMBL. 21684157
IC50 (binding) = 170 nM Inhibition of human iNOS expressed in human DLD1 cells after 1 hr ChEMBL. 18024030
IC50 (binding) = 170 nM Inhibition of human iNOS expressed in human DLD1 cells after 1 hr ChEMBL. 18024030
IC50 (binding) = 210 nM Inhibition of cytokine-induced iNOS activity in human DLD1 cells after 24 hrs ChEMBL. 18024030
IC50 (binding) = 210 nM Inhibition of cytokine-induced iNOS activity in human DLD1 cells after 24 hrs ChEMBL. 18024030
IC50 (binding) = 840 nM Inhibition of human nNOS expressed in insect SF9 cells after 1 hr ChEMBL. 18024030
IC50 (binding) = 840 nM Inhibition of human nNOS expressed in insect SF9 cells after 1 hr ChEMBL. 18024030
IC50 (binding) = 0.035 uM Inhibition of human iNOS ChEMBL. 18849972
IC50 (binding) = 0.037 uM In vitro inhibition of human Inducible nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) = 0.037 uM Inhibitory activity of compound against human inducible nitiric oxide synthase ChEMBL. 12620067
IC50 (binding) = 0.037 uM In vitro inhibition of human Inducible nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) = 0.037 uM Inhibitory activity of compound against human inducible nitiric oxide synthase ChEMBL. 12620067
IC50 (binding) = 0.041 uM Inhibition of human recombinant iNOS ChEMBL. 21398123
IC50 (binding) = 0.1 uM Inhibition of human ERG ChEMBL. 21398123
IC50 (binding) = 0.74 uM In vitro inhibition of human neuronal nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) = 0.74 uM In vitro inhibition of human neuronal nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) = 0.79 uM Inhibition of human nNOS ChEMBL. 18849972
IC50 (functional) = 0.9 uM Inhibitory activity against synthesis of inducible nitiric oxide synthase by DLD-1 cells ChEMBL. 12620067
IC50 (binding) = 0.9 uM Inhibition of human iNOS by whole cell assay ChEMBL. 18849972
IC50 (functional) = 0.9 uM Inhibitory activity against synthesis of inducible nitiric oxide synthase by DLD-1 cells ChEMBL. 12620067
IC50 (binding) = 1 uM Inhibitory activity against human neuronal nitiric oxide synthase ChEMBL. 12620067
IC50 (binding) = 1 uM Inhibitory activity against human neuronal nitiric oxide synthase ChEMBL. 12620067
IC50 (binding) = 1 uM Inhibition of iNOS in intact human DLD1 cells assessed as nitric oxide production ChEMBL. 21398123
IC50 (binding) > 100 uM In vitro inhibition of human endothelial nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) > 100 uM In vitro inhibition of human endothelial nitric oxide synthase. ChEMBL. 15163211
IC50 (binding) > 100 uM Inhibition of human eNOS ChEMBL. 18849972
ID50 (functional) = 3 uM kg-1 Inhibition of LPS induced nitrite production in rat following 4 hr of oral administration ChEMBL. 12620067
Inhibition (binding) < 15 % Inhibition of human eNOS expressed in insect SF9 cells at 10 uM after 1 hr ChEMBL. 18024030
Inhibition (binding) < 15 % Inhibition of human eNOS expressed in insect SF9 cells at 10 uM after 1 hr ChEMBL. 18024030
Inhibition (binding) < 20 % Percentage inhibition of human endothelial nitric oxide synthase (eNOS) at 100 uM ChEMBL. 15163211
Inhibition (binding) < 20 % Percentage inhibition of human endothelial nitric oxide synthase (eNOS) at 100 uM ChEMBL. 15163211
Inhibition (binding) = 50 % Inhibitory activity of 100 uM compound against human endothelial nitiric oxide synthase; Range is 25%-50% ChEMBL. 12620067
Inhibition (binding) = 50 % Inhibitory activity of 100 uM compound against human endothelial nitiric oxide synthase; Range is 25%-50% ChEMBL. 12620067
Ratio IC50 (binding) = 5 Selectivity for human nNOS to human iNOS ChEMBL. 18024030
Ratio IC50 (binding) > 70 Selectivity for human eNOS to human iNOS ChEMBL. 18024030
Stability (ADMET) < 3 uL/min Metabolic stability in human hepatocytes assessed as per 10'6 cells ChEMBL. 21398123

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 12620067

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

6 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.